78 related articles for article (PubMed ID: 4658408)
41. ZD-6126 AstraZeneca.
Soltau J; Drevs J
IDrugs; 2004 Apr; 7(4):380-7. PubMed ID: 15057644
[TBL] [Abstract][Full Text] [Related]
42. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
[TBL] [Abstract][Full Text] [Related]
43. [Experience with use of mustoforan at the Clinical Oncological Dispensary of the Republic of Tatarstan].
Karpenko LG
Vopr Onkol; 2005; 51(3):388-90. PubMed ID: 16279110
[No Abstract] [Full Text] [Related]
44. [Our experiences with polychemotherapy of malignant endothoracic tumors (103 cases)].
Molina C; Cheminat JC; Passemard N; Adam J
Poumon Coeur; 1968; 24(1):103-9. PubMed ID: 4968015
[No Abstract] [Full Text] [Related]
45. Real-time quantification of the multidrug resistance-1 gene expression in relapsed acute promyelocytic leukemia treated with arsenic trioxide.
Au WY; Chim CS; Wai Lie AK; Pang A; Kwong YL
Haematologica; 2002 Oct; 87(10):1109-11. PubMed ID: 12368167
[No Abstract] [Full Text] [Related]
46. [Results and current biological bases of therapy of malignant hemoreticulopathies].
Berceanu S; Gociu M; Geib R; Sighetea E; Dăncescu I; Segal E; Tănăsescu C
Stud Cercet Med Interna; 1971; 12(3):211-28. PubMed ID: 5002655
[No Abstract] [Full Text] [Related]
47. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
[No Abstract] [Full Text] [Related]
48. Treatment of polycythaemia vera with Myelobromol.
Nagy G; Petrányi G; Arany L; Rácz M
Ther Hung; 1969; 17(3):123-6. PubMed ID: 5351155
[No Abstract] [Full Text] [Related]
49. Complete Responses in the TEMPI Syndrome after Treatment with Daratumumab.
Sykes DB; Schroyens W
N Engl J Med; 2018 Jun; 378(23):2240-2242. PubMed ID: 29874534
[No Abstract] [Full Text] [Related]
50. [Present status of radiophosphorus therapy of polycythemia with reference to personal experiences].
Hoffmann G; Stephan F; Predic M; Keiderling W
Nucl Med (Stuttg); 1963; 2():Suppl 1:347-59. PubMed ID: 5900130
[No Abstract] [Full Text] [Related]
51. [Trial treatment of bronchial cancer by polychemotherapy].
Mignon A; Tournant A; Meyer A
Poumon Coeur; 1968; 24(1):93-6. PubMed ID: 4969372
[No Abstract] [Full Text] [Related]
52. Differentiation syndrome with lethal lung injury after arsenic trioxide treatment for myelodysplastic syndrome.
Ofran Y; Avivi I; Gesundheit B; Or R; Rowe JM; Zuckerman T
Am J Hematol; 2007 Apr; 82(4):332-3. PubMed ID: 17080434
[No Abstract] [Full Text] [Related]
53. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
Hsiao YY; Bardos TJ
J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
[No Abstract] [Full Text] [Related]
54. Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
Kälkner KM; Ullén A; Wersäll P; Cohn-Cedermark G
Acta Oncol; 2007; 46(6):862-3. PubMed ID: 17653913
[No Abstract] [Full Text] [Related]
55. Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
Masamoto Y; Nannya Y; Arai S; Koike Y; Hangaishi A; Yatomi Y; Kurokawa M
Br J Haematol; 2009 Mar; 144(5):798-9. PubMed ID: 19036092
[No Abstract] [Full Text] [Related]
56. What is objective tumor response?
Rimm AA; Ahlstrom JK; Bross ID
Cancer; 1967 Aug; 20(8):1326-34. PubMed ID: 5340072
[No Abstract] [Full Text] [Related]
57. [Clinical significance of reactive polyglobulia].
Marx HH; Struck F
Beitr Klin Erforsch Tuberk Lungenkr; 1969 Sep; 141(1):169-73. PubMed ID: 5351256
[No Abstract] [Full Text] [Related]
58. [Treatment of polycythemia with imiphos].
Silkina AG; Zatsepilin AT
Vrach Delo; 1972 Oct; 10():52-4. PubMed ID: 4658408
[No Abstract] [Full Text] [Related]
59. [Treatment of erythremia with imifos (10-year experience with hospital and ambulatory treatment of patients)].
Demidova AV; Shcherbak EM; Kozlova AF
Ter Arkh; 1975; 47(1):56-62. PubMed ID: 1114449
[No Abstract] [Full Text] [Related]
60. [Use of imiphos and myelobromol in erythremias under polyclinic conditions].
Osechenskaia GV; Krasiukova LI; Nikolaeva NV; Protasova TG
Probl Gematol Pereliv Krovi; 1972 Oct; 17(10):34-8. PubMed ID: 4668399
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
